Pular para o conteúdo principal
Ranking Invest

HUMA - Humacyte, Inc.

Segmento: HealthcareHumacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Análise Ranking Invest

Valor de Mercado
$ 130.59 Mi
IVR
-2.46Índice proprietário de comparação relativa: -2,46.
IVR2
-2.74Leitura proprietária complementar: -274%.
MLL
-2.74Leitura proprietária complementar: -274%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 31.26 Mi

Dívida Líquida

-$ 43.58 Mi

L4T

-$ 96.73 Mi

MM4T

-5065.16%

Indicadores Básicos

ROE

-309.44%

Índices de Previsibilidade

Receita Líquida

G1.30

Lucro

D0.61

Margem

E1.09

Índices de Tendência

Receita Líquida

D2.25

Lucro

D0.59

Margem

F-6.30

Índices de Endividamento

DIV/PAT

-1.39

DIV/L4T

0.45

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.